The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
13:42 27-Jun-2016 VRP Result of AGM PRN -6.43% Down
07:00 20-Jun-2016 VRP Proposed Placing and Notice of General Meeting PRN +23.89% Up
16:54 17-Jun-2016 VRP Proposed Placing and Notice of General Meeting PRN +18.98% Up
17:26 03-Jun-2016 VRP 2015 Annual Report and Accounts, Notice of AGM PRN -12.06% Down
07:00 03-Jun-2016 VRP Final Results PRN -12.06% Down
14:48 27-May-2016 VRP Notice of Results PRN -3.68% Down
07:00 10-May-2016 VRP Add-on Phase II RPL554 study PRN +2.96% Up
07:00 04-May-2016 VRP Verona to present RPL554 at the ATS Conference PRN +11.17% Up
15:16 19-Apr-2016 VRP Change of Registered Office PRN -5.24% Down
16:08 15-Apr-2016 VRP Holding(s) in Company RNS -1.97% Down
07:00 21-Mar-2016 VRP Verona Pharma: 2015 in review PRN -14.73% Down
07:00 15-Mar-2016 VRP Positive results from RPL554 dose-finding study PRN -2.62% Down
14:47 10-Feb-2016 VRP Grant of Share Options PRN +0.45% Up
12:24 21-Jan-2016 VRP Director Dealing RNS +11.92% Up
07:00 11-Jan-2016 VRP Directorate Change PRN -4.33% Down
16:02 03-Dec-2015 VRP Director Dealing PRN +4.48% Up
17:11 01-Dec-2015 VRP Holding(s) in Company RNS +2.07% Up
07:00 11-Nov-2015 VRP RPL554 paper published in American Journal of Physiology PRN -4.24% Down
07:00 05-Nov-2015 VRP Patient enrolment completed in RPL554 PhIIa studies PRN -3.63% Down
07:00 14-Oct-2015 VRP Start of RPL554 Phase IIa combination study PRN -

 Page 1 of 2

| 1 | 2 | Next

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.


Company Information
Updated Monthly
Company address 3 More London Riverside, London, SE1 2RE, United Kingdom
Company website http://www.veronapharma...
Market cap(in millions)* £ 34.34
Listing/Admission to trading 19 Sep 2006
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AIM
MiFID Status MTF
Exchange market size 50,000
ISIN number GB00B06GSH43

Start trading your favourite asset CFDs!
Carries risk of capital loss

VERONA PHARMA share news analysis (VRP)